Search

Bills by Topic Results

Bills that have passed the Legislature are shown in bold text with an * preceding them.

DRUGS  DRUGS RSS Feed
               (See also PHARMACIES AND PHARMACISTS; TRAFFIC OFFENSES)
Advertising of pharmaceuticals, sale of, B&O tax surcharge, revenue use: SB 5659
Antibiotics, for Lyme disease, long-term therapy, authority for: HB 2332
Biological products, interchangeable, confirmation for dispensing of: * HB 2251, CH 21 (2020)
Cannabidiol products, marijuana retailer sales of: HB 1238, HB 2300, SB 5201, SB 6269
Cannabis, cannabis science task force, establishing: * HB 2052, CH 277 (2019)
Cannabis, licensee business practices, benefits, and policies: HB 2361, SB 6393, SSB 6393
Cannabis, medical use, provisions: HB 1060, HB 1094, * ESHB 1094, CH 203 (2019), HB 1095, * SHB 1095, CH 204 (2019), HB 2546, HB 2612, HB 2740, HB 2743, SB 5234, SB 5442, SB 5498, SSB 5498, SB 5599, SB 6332
Cannabis, product testing laboratories, accreditation program for: * HB 2052, CH 277 (2019)
Cannabis, Washington cannabis commission, and advisory council, creating: HB 1974, SHB 1974, 2SHB 1974
Cannabis, Washington cannabis commission, creating: SB 6589
Controlled substance tableting/encapsulating machine, sale/etc., class C felony: SHB 2375
Controlled substance, endangerment with a, adding fentanyl to crime of: SB 6022, SSB 6022
Controlled substance, unlawful possession of, reducing to gross misdemeanor: HB 2835
Controlled substances, illegal consumption in child's presence, sentencing: HB 1700
Controlled substances, tableting/encapsulating/imitation equipment, prohibitions: HB 2375, SB 6159
Controlled substances, uniform act, property forfeiture under: SB 5060
Controlled substances, uniform act, property seizure and forfeiture under: SB 6266, SSB 6266
Epinephrine autoinjectors, in schools, EpiPen work group, establishing: HB 2428
Epinephrine autoinjectors, in schools, prescriptions/supplies, report on: SHB 2428
Fentanyl, adding to crime of endangerment with a controlled substance: SB 6022, SSB 6022
Fentanyl, manufacture of, moving from drug offense seriousness level II to III: SB 6583
Food and drug administration, U.S., disclosure exemption for certain records: * HB 1385, CH 337 (2019), SB 5455
Illegal drugs, past manufacture on residential property, seller disclosure: SB 5391, SSB 5391
Illegal use, safe injection sites, prohibiting, and state regulatory preemption: HB 2112
Illegal use, supervised injection sites, city or county ordinance prohibiting: HB 2658
Insulin drugs, wholesale price increase notification: SB 5371
Insulin products, central insulin purchasing work group, establishing: SB 6113, SSB 6113
Insulin, insurance cost-sharing cap for: HB 2662, SHB 2662, * E2SHB 2662, CH 346 (2020)
Insulin, total cost of insulin work group, establishing: HB 2662, SHB 2662, * E2SHB 2662, CH 346 (2020)
Marijuana, as contraband on state correctional institution premises: SHB 1871, 2SHB 1871
Marijuana, business or nonprofit entity, licensing and residency: HB 1236, SHB 1236, HB 1289, HB 2263, SB 5202, SB 5409, SB 5985, SB 6085
Marijuana, businesses, administrative violations: HB 1237, SHB 1237, 2SHB 1237, SB 5318, * ESSB 5318, CH 394 (2019)
Marijuana, businesses, advertising to minors, prohibiting: HB 1238, HB 2321, SB 5201, SB 6333
Marijuana, businesses, advertising, reducing youth exposure to: HB 2350, SB 6657
Marijuana, businesses, agreements with, trademarks and intellectual property: HB 1794, * ESHB 1794, CH 380 (2019)
Marijuana, businesses, billboards: HB 1466, HB 2321, HB 2350, SB 5785, SB 6333, SB 6657
Marijuana, businesses, budtender permits for retailers and employees: HB 1370, SHB 1370, SB 5678
Marijuana, businesses, cannabidiol products: HB 1238, HB 2300, SB 5201, SB 6269
Marijuana, businesses, compliance and enforcement reform: HB 1237, SHB 1237, 2SHB 1237, SB 5318, * ESSB 5318, CH 394 (2019)
Marijuana, businesses, craft marijuana producer license, creating: HB 2279
Marijuana, businesses, craft marijuana producer/processor license, creating: HB 2279
Marijuana, businesses, craft marijuana producers/processors advisory group: HB 2279
Marijuana, businesses, delivery endorsement to retailer license: HB 1358
Marijuana, businesses, equity loan program and advisory board, creating: HB 2263, SB 6085
Marijuana, businesses, labor peace agreements: HB 1289, SB 5985
Marijuana, businesses, license limits in aggregate: HB 2817, SB 6661
Marijuana, businesses, licensee business practices, benefits, and policies: HB 2361, SB 6393, SSB 6393
Marijuana, businesses, licensee limits, prohibitions: HB 1289, SB 5985
Marijuana, businesses, marijuana merchandise: HB 1238, SB 5201
Marijuana, businesses, marijuana odor, task force on, establishing: SB 6089
Marijuana, businesses, outdoor advertising at stadium or raceway, when: SB 5969
Marijuana, businesses, prohibiting licensing due to objection based on zoning: HB 2247
Marijuana, businesses, qualifying applicant premises, compliance certificate: HB 2359, SHB 2359, SB 6206, * SSB 6206, CH 154 (2020)
Marijuana, businesses, retail employee crimes involving underage persons: * HB 1792, CH 379 (2019)
Marijuana, businesses, retail outlets, maximum number, social equity goals: HB 2870, SB 6604
Marijuana, businesses, retail outlets, number that may be licensed in state: HB 2817, SB 6661
Marijuana, businesses, retail outlets, robbery incident details, forwarding: SB 6033, SSB 6033
Marijuana, businesses, retail outlets, robbery of, special allegation: SB 6033, SSB 6033
Marijuana, businesses, siting and advertising near children: HB 1003
Marijuana, businesses, transfers, holding companies, and management: HB 1289
Marijuana, cannabis science task force, establishing: * HB 2052, CH 277 (2019)
Marijuana, compliant products, sales and use tax exemptions applicability to: * ESSB 5298, CH 393 (2019)
Marijuana, cultivation or possession in a residence: HB 1131, SB 5155
Marijuana, enforcement, powers of liquor enforcement officers: HB 1626
Marijuana, excise tax distributions for vulnerable persons: HB 2900
Marijuana, excise tax provisions: HB 1959, HB 2900
Marijuana, financiers of licensees, money source and criminal history of: HB 1963
Marijuana, licenses, social equity in marijuana, legislative task force on: SHB 2870, * E2SHB 2870, CH 236 (2020)
Marijuana, medical use, compassionate care renewals: HB 1094, * ESHB 1094, CH 203 (2019), SB 5498, SSB 5498
Marijuana, medical use, consumption by students: HB 1060, HB 1095, * SHB 1095, CH 204 (2019), SB 5442
Marijuana, medical use, estimating medical market demand: SB 5599
Marijuana, medical use, medical marijuana authorization database, funding: HB 1415, * SHB 1415, CH 220 (2019), SB 5482
Marijuana, medical use, recognition cards and excise tax exemption: HB 2743, SB 5234
Marijuana, medical use, recognition cards and valid authorizations: HB 2612
Marijuana, medical use, THC concentration: HB 2546, SB 6332
Marijuana, medical use, various provisions: HB 2612
Marijuana, medical use, when employer required to have drug-free workplace: HB 2740
Marijuana, operating watercraft under influence of, criminal offenses: HB 2431, SHB 2431
Marijuana, possession, misdemeanor convictions, vacation of: HB 1500, SHB 1500, * SB 5605, CH 400 (2019)
Marijuana, processor license, forfeiture for failing to be operational, limiting: HB 2817, SB 6661
Marijuana, producer license, forfeiture for failing to be operational, limiting: HB 2817, SB 6661
Marijuana, producer license, home delivery endorsement, establishing: HB 2871, SB 6603
Marijuana, producer license, retail privilege endorsement, establishing: HB 2871, SB 6603
Marijuana, producer or processor license, direct sales endorsement: HB 1945, HB 1995
Marijuana, product labels and labeling, requirements: HB 1250, SB 5298, * ESSB 5298, CH 393 (2019)
Marijuana, product testing laboratories, accreditation program for: * HB 2052, CH 277 (2019)
Marijuana, production, square footage of plant canopy permitted in production: HB 2817, SB 6661
Marijuana, products, infused edible, requiring cold storage or pasteurization: HB 2726
Marijuana, products, THC concentration, producer/retailer restrictions: HB 2546, SB 6332
Marijuana, products/infused products, various liquor and marijuana permits: HB 1945
Marijuana, products/infused products, various provisions: HB 1945, HB 2726
Marijuana, retail license, for municipal corporation, commission, or authority: SB 5599
Marijuana, retail license, marijuana consumption lounge special endorsement: HB 1945
Marijuana, retail licenses, additional, social equity program for: HB 2870, SB 6604
Marijuana, retail licenses, community of color applicants as priority: HB 2870, SHB 2870, SB 6604
Marijuana, retail licenses, increasing maximum number, social equity goals: HB 2870, SB 6604
Marijuana, retail licenses, social equity grant program for: * E2SHB 2870, CH 236 (2020)
Marijuana, retail licenses, social equity program for: SHB 2870
Marijuana, retail licenses, technical assistance competitive grant program: HB 2870, SHB 2870, * E2SHB 2870, CH 236 (2020), SB 6604
Marijuana, retailer license, forfeiture for failing to be operational, limiting: HB 2817, SB 6661
Marijuana, retailers/co-owners, aggregate licenses per business, raising limit: HB 2817, SB 6661
Marijuana, sales price differentials, permitting, when: SB 6057
Marijuana, screening tests/results for prospective or newly hired employees: HB 2740
Marijuana, traceability system, state auditor to audit and report: HB 2076
Marijuana, use in hotel, motel, or inn guest rooms, unlawful, when: HB 2199
Marijuana, Washington cannabis commission, and advisory council, creating: HB 1974, SHB 1974, 2SHB 1974
Marijuana, Washington cannabis commission, creating: SB 6589
Marketing/advertising to minors via internet/mobile application, prohibitions: HB 2442
Naloxone, co-prescribing with opioid drug prescription, when: HB 2337, SB 6447, SSB 6447
Naloxone, grades 5-12 and higher education access: SSB 5464
Naloxone, grades 7-12 and higher education access: SB 5464
Naloxone, K-12 and higher education access: HB 1039, SHB 1039, 2SHB 1039
Offenses, criminal, persons convicted of, resentencing hearings for: SSB 5848, SB 5867, * SSB 5867, CH 55 (2020)
Offenses, seizure and forfeiture of property: HB 1269, SHB 1269
Offenses, seizure and forfeiture of property, recordkeeping and reporting: SB 6266, SSB 6266
Opioid agonist/antagonist products, medicaid managed care coverage: HB 2418
Opioid overdose medication, co-prescribing with opioid drug prescription: HB 2337, SB 6447, SSB 6447
Opioid overdose medication, grades 5-12 and higher education access: SSB 5464
Opioid overdose medication, grades 7-12 and higher education access: SB 5464
Opioid overdose medication, high school and higher education access: * SSB 5380, CH 314 (2019)
Opioid overdose medication, K-12 and higher education access: HB 1039, SHB 1039, 2SHB 1039
Opioid overdose medication, provisions: HB 1331, SHB 1331, 2SHB 1331, HB 2337, SB 5380, * SSB 5380, CH 314 (2019), SB 6447, SSB 6447
Opioid pollution, reduction permits for pollution control facilities: SB 5657
Opioid use disorder, medication for, pharmacy use of remote dispensing sites: SHB 2335, * SSB 6086, CH 244 (2020)
Opioid use disorder, patients receiving treatment, 2-week medication supply: HB 2335, SB 6086
Opioid use disorder, persons presenting with, certified peer counselor services: SSB 6311, 2SSB 6311
Opioid use disorder, persons presenting with, required facility services for: SB 6311, SSB 6311, 2SSB 6311
Opioids, advisory council on state use of money from litigation, convening: HB 2786
Opioids, advisory council on state use of penalties from litigation, convening: ESHB 2786
Opioids, certain practitioners prescribing, limiting liability of, when: HB 2807
Opioids, prescription, B&O surtax on persons warehousing and reselling: SB 5940
Opioids, prescription, impact fees, manufacturers to pay, when: HB 2438, SHB 2438
Opioids/other drugs, crisis services, enhanced 211 drug line pilot project: SB 5546
Over-the-counter drugs, athletic trainer purchase/administration of, when: HB 1689, SB 5688, * ESSB 5688, CH 358 (2019)
Prescription drug affordability board, establishing: SB 6088, * SSB 6088 (2020) V
Prescription monitoring program, insulin drug wholesale price increases: SB 5371
Prescription monitoring program, opioid prescribing and health records: HB 1331, SHB 1331, 2SHB 1331, SB 5380, * SSB 5380, CH 314 (2019)
Prescription, advisory council on state use of money from opioid litigation: HB 2786
Prescription, advisory council on state use of penalties from opioid litigation: ESHB 2786
Prescription, athletic trainer purchase/administration of, when: HB 1689, SB 5688, * ESSB 5688, CH 358 (2019)
Prescription, compounding of drugs, requirements: HB 1352, SHB 1352, SB 5663
Prescription, cost and utilization data, reporting: HB 1224, SHB 1224, * E2SHB 1224, CH 334 (2019), SB 5251, SB 5292, SSB 5292, 2SSB 5292
Prescription, cost and utilization data, uses/disclosure/requirement dates: HB 2710
Prescription, cost growth benchmark/data/reviews/transparency/mitigation: * SSB 6088 (2020) V
Prescription, cost transparency, data uses/disclosure/requirement dates: HB 2710
Prescription, cost transparency, reporting for: HB 1224, SHB 1224, * E2SHB 1224, CH 334 (2019), SB 5251, SB 5292, SSB 5292, 2SSB 5292, SB 5422
Prescription, covered, maximum point-of-sale cost for: HB 2464, * SHB 2464, CH 116 (2020)
Prescription, department of corrections pharmacy, returned medications reuse: SB 6526, * SSB 6526, CH 264 (2020)
Prescription, donated open bulk containers or medication cards, reuse: SB 6526, * SSB 6526, CH 264 (2020)
Prescription, drug utilization management protocol, use of: HB 1879, * ESHB 1879, CH 171 (2019), SB 5806
Prescription, electronic communication to pharmacy of: 2SHB 1331, SB 5446
Prescription, from Canada, wholesale drug importation program, establishing: SB 6110
Prescription, high-annual-cost, emerging therapies work group, establishing: HB 1869, SHB 1869
Prescription, mail order services, unintentional use/enrollment: SB 5184, SSB 5184
Prescription, medicare, employer group waiver plans, supplemental coverage: HB 2210, SB 6051, * SSB 6051, CH 196 (2020)
Prescription, mercury-containing, prohibitions and requirements: HB 1276
Prescription, naturopath drug and controlled substance prescribing: SHB 1630
Prescription, naturopath legend drug and controlled substance prescribing: HB 1630, SB 5752
Prescription, northwest prescription drug consortium, role of: SB 6113, SSB 6113
Prescription, opioid agonist/antagonist products, medicaid managed care: HB 2418
Prescription, opioids, impact fees, manufacturers to pay, when: HB 2438, SHB 2438
Prescription, opioids, prescribing of, requirements: HB 1331, SHB 1331, 2SHB 1331, HB 2337, SB 5380, * SSB 5380, CH 314 (2019), SB 6447, SSB 6447
Prescription, pharmacy tourism programs for obtaining drugs outside U.S.: SB 6111
Prescription, prescription drug consortium, role of: HB 2662, SHB 2662, * E2SHB 2662, CH 346 (2020)
Prescription, psychiatric pharmacist practitioners, role of: HB 2888, SB 6609
Prescription, psychologists, certification for prescriptive authority: HB 2967
Prescription, step therapy exception requests: * ESHB 1879, CH 171 (2019)
Prescription, warehousing/reselling, preferential B&O tax rate, eliminating: HB 2734
Prescription, warehousing/reselling, preferential B&O tax rate, repealing: SB 5988
Prescription, wholesale drug importation program, design/implementation of: SB 6110